Drug interaction between sevelamer and cyclosporin

被引:10
作者
Guillen-Anaya, MA [1 ]
Jadoul, M
机构
[1] Clin Univ St Luc, Brussels, Belgium
[2] Catholic Univ Louvain, Serv Nephrol, B-1200 Brussels, Belgium
关键词
D O I
10.1093/ndt/gfg522
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
引用
收藏
页码:515 / 515
页数:1
相关论文
共 5 条
[1]   Bile acid binding to sevelamer HCl [J].
Braunlin, W ;
Zhorov, E ;
Guo, A ;
Apruzzese, W ;
Xu, QW ;
Hook, P ;
Smisek, DL ;
Mandeville, WH ;
Holmes-Farley, SR .
KIDNEY INTERNATIONAL, 2002, 62 (02) :611-619
[2]   Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients [J].
Chertow, GM ;
Burke, SK ;
Raggi, P .
KIDNEY INTERNATIONAL, 2002, 62 (01) :245-252
[3]   End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy - Risk of development and treatment [J].
Gonwa, TA ;
Mai, ML ;
Melton, LB ;
Hays, SR ;
Goldstein, RM ;
Levy, MF ;
Klintmalm, GB .
TRANSPLANTATION, 2001, 72 (12) :1934-1939
[4]   The incidence of end-stage renal failure in 17 years of heart transplantation: A single center experience [J].
Satchithananda, DK ;
Parameshwar, J ;
Sharples, L ;
Taylor, GJ ;
McNeil, K ;
Wallwork, J ;
Large, SR .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2002, 21 (06) :651-657
[5]   ABSORPTION OF CYCLOSPORINE FROM CONVENTIONAL AND NEW MICROEMULSION ORAL FORMULATIONS IN LIVER-TRANSPLANT RECIPIENTS WITH EXTERNAL BILIARY DIVERSION [J].
TRULL, AK ;
TAN, KKC ;
TAN, L ;
ALEXANDER, GJM ;
JAMIESON, NV .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 39 (06) :627-631